Q4FY24 EARNING CALENDAR: ASHOKLEY, GLENMARK, HINDALCO, NTPC, SUNTV, UNITDSPR, TORRENTPHRM

અમદાવાદ, 24 મેઃ કંપનીઓ દ્વારા માર્ચ-24ના અંતે પુરાં થયેલા ચોથા ત્રિમાસિક/ વાર્ષિક પરીણામો અંગે નિષ્ણાતો, બજાર અગ્રણીઓ, બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી રજૂ કરાયેલા અનુમાનો રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

24.05.2024: 63MOONS, AFFLE, ASHOKLEY, ASTRAMICRO, AVL, BOROLTD, BOSCHLTD, CENTURYPLY, COCHINSHIP, CORDSCABLE, DOMS, EASEMYTRIP, EIDPARRY, GLENMARK, GREENPOWER, HAPPYFORGE, HCC, HINDALCO, HINDCOPPER, HUDCO, IBULHSGFIN, IKIO, JAMNAAUTO, KALAMANDIR, KHADIM, KOLTEPATIL, KTKBANK, MANAPPURAM, NAZARA, NIITLTD, NTPC, PIXTRANS, PNCINFRA, PSPPROJECT, RICOAUTO, RKSWAMY, SPARC, STOVEKRAFT, SUNFLAG, SUNTV, SUZLON, TORNTPHARM, UNITDSPR, ZFCVINDIA

ASHOKLEY

 Revenue expected at Rs 11,185 crore versus Rs 11,625 crore

 EBITDA expected to be seen at Rs 1477 crore versus Rs 1276 crore

 EBITDA margin expected to be seen at 13.2% versus 11.0%

 Net profit expected to be seen at Rs 812 crore versus Rs 715 crore

GLENMARK

 Revenue expected at Rs 3220 crore versus Rs 3300 crore

 EBITDA expected to be seen at Rs 517 crore versus Rs 605 crore

 EBITDA margin expected to be seen at 16.05% versus 18.33%

 Net profit expected to be seen at Rs 231 crore versus Rs 371 crore

HINDALCO

 Revenue expected at Rs 54,722 crore versus Rs 55,857 crore

 EBITDA expected to be seen at Rs 6633 crore versus Rs 5327 crore

 EBITDA margin expected to be seen at 12.12% versus 9.53%

 Net profit expected to be seen at Rs 2839 crore versus Rs 2411 crore

NTPC

 Revenue expected at Rs 44,862 crore versus Rs 41,317 crore

 EBITDA expected to be seen at Rs 13,167 crore versus Rs 11,109 crore

 EBITDA margin expected to be seen at 29.3% versus 26.9%

 Net profit expected to be seen at Rs 5737 crore versus Rs 5672 crore

SUNTV

 Revenue expected at Rs 861 crore versus Rs 840 crore

 EBITDA expected to be seen at Rs 513 crore versus Rs 497 crore

 EBITDA margin expected to be seen at 59.6% versus 59.2%

 Net profit expected to be seen at Rs 406 crore versus Rs 380 crore

TORNTPHARM

 Revenue expected at Rs 2781 crore versus Rs 2491 crore

 EBITDA expected to be seen at Rs 883 crore versus Rs 727 crore

 EBITDA margin expected to be seen at 31.7% versus 29.2%

 Net profit expected to be seen at Rs 446 crore versus Rs 287 crore

UNITDSPR

 Revenue expected at Rs 2650 crore versus Rs 2503 crore

 EBITDA expected to be seen at Rs 353 crore versus Rs 236 crore

 EBITDA margin expected to be seen at 13.3% versus 9.4%

 Net profit expected to be seen at Rs 247 crore versus Rs 103 crore

25.05.2024: ALLCARGO, AUROPHARMA, BLUEJET, DIVISLAB, GENUSPAPER, PARAS, RPOWER, SARDAEN, VADILALIND, WPIL, ZUARI

AUROPHARMA

 Revenue expected at Rs 7322 crore versus Rs 6473 crore

 EBITDA expected to be seen at Rs 1551 crore versus Rs 996 crore

 EBITDA margin expected to be seen at 21.18% versus 15.39%

 Net profit expected to be seen at Rs 841 crore versus Rs 506 crore

DIVISLAB

 Revenue expected at Rs 2098 crore versus Rs 1950 crore

 EBITDA expected to be seen at Rs 602 crore versus Rs 487 crore

 EBITDA margin expected to be seen at 28.6% versus 24.9%

 Net profit expected to be seen at Rs 458 crore versus Rs 321 crore

27.05.2024: ASTRAZEN, DCMSRIND, DISHTV, ELGIEQUIP, FLAIR, GARFIBRES, GKP, GMDCLTD, GOODYEAR, HBLPOWER, HERANBA, IFBIND, JAICORPLTD, JINDWORLD, KIRLOSIND, LAXMIMACH, LICI, LUMAXTECH, MSTCLTD, NATCOPHARM, NATIONALUM, NMDC, NRBBEARING, SATIA, SIGACHI, SUMICHEM, TARC, TBZ, TVSSCS, VPRPL

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)